WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, September 24, 2003, 23(25):8682-8691

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dong, H.
Right arrow Articles by McDonald, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dong, H.
Right arrow Articles by McDonald, J. W.

 Previous Article  |  Next Article 

Cellular/Molecular
Enhanced Oligodendrocyte Survival after Spinal Cord Injury in Bax-Deficient Mice and Mice with Delayed Wallerian Degeneration

Hongxin Dong,1 Alicia Fazzaro,1 Chuanxi Xiang,1 Stanley J. Korsmeyer,4 Mark F. Jacquin,1 and John W. McDonald1,2,3

1Department of Neurology, Spinal Cord Injury Neuro-Rehabilitation Section, Restorative Treatment and Research Program, and Center for the Study of Nervous System Injury, Departments of 2Neurological Surgery, Anatomy, and 3Neurobiology, Washington University School of Medicine, St. Louis, Missouri 63108, and 4Howard Hughes Medical Institute, Dana Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts 02115

Mechanisms of oligodendrocyte death after spinal cord injury (SCI) were evaluated by T9 cord level hemisection in wild-type mice (C57BL/6J and Bax+/+ mice), Wlds mice in which severed axons remain viable for 2 weeks, and mice deficient in the proapoptotic protein Bax (Bax-/-). In the lateral white-matter tracts, substantial oligodendrocyte death was evident in the ipsilateral white matter 3-7 mm rostral and caudal to the hemisection site 8 d after injury. Ultrastructural analysis and expression of anti-activated caspase-3 characterized the ongoing oligodendrocyte death at 8 d as primarily apoptotic. Oligodendrocytes were selectively preserved in Wlds mice compared with C57BL/6J mice at 8 d after injury, when severed axons remained viable as verified by antereograde labeling of the lateral vestibular spinal tract. However, 30 d after injury when the severed axons in Wlds animals were already degenerated, the oligodendrocytes preserved at 8 d were lost, and numbers were then equivalent to control C57BL/6J mice.

In contrast, oligodendrocyte death was prevented at both time points in Bax-/- mice. When cultured oligodendrocytes were exposed to staurosporine or cyclosporin A, drugs known to stimulate apoptosis in oligodendrocytes, those from Bax-/- mice but not from Bax+/+ or Bax+/- mice were resistant to the apoptotic death. In contrast, the three groups were equally vulnerable to excitotoxic necrosis death induced by kainate. On the basis of these data, we hypothesize that the Wallerian degeneration of white matter axons that follows SCI removes axonal support and induces apoptotic death in oligodendrocytes by triggering Bax expression.

Key words: apoptosis; spinal cord hemisection; oligodendrocyte death; Wlds mutation; Bax deficiency; Bax-/-; Wallerian degeneration; immunohistochemistry


Received Feb 19, 2003; revised June 5, 2003; accepted June 26, 2003.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
G. Nocentini, S. Cuzzocrea, T. Genovese, R. Bianchini, E. Mazzon, S. Ronchetti, E. Esposito, D. P. Rosanna, P. Bramanti, and C. Riccardi
Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related (GITR)-Fc Fusion Protein Inhibits GITR Triggering and Protects from the Inflammatory Response after Spinal Cord Injury
Mol. Pharmacol., June 1, 2008; 73(6): 1610 - 1621.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Cuzzocrea, T. Genovese, E. Mazzon, C. Crisafulli, R. Di Paola, C. Muia, M. Collin, E. Esposito, P. Bramanti, and C. Thiemermann
Glycogen Synthase Kinase-3beta Inhibition Reduces Secondary Damage in Experimental Spinal Cord Trauma
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 79 - 89.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Arundine, M. Aarts, A. Lau, and M. Tymianski
Vulnerability of Central Neurons to Secondary Insults after In Vitro Mechanical Stretch
J. Neurosci., September 15, 2004; 24(37): 8106 - 8123.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. P. Stirling, K. Khodarahmi, J. Liu, L. T. McPhail, C. B. McBride, J. D. Steeves, M. S. Ramer, and W. Tetzlaff
Minocycline Treatment Reduces Delayed Oligodendrocyte Death, Attenuates Axonal Dieback, and Improves Functional Outcome after Spinal Cord Injury
J. Neurosci., March 3, 2004; 24(9): 2182 - 2190.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-